The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
4626843 5774036 I 4626843-7 20050207 20050315 20050331 EXP 2005BI006385 BIOGEN IDEC INC. 26 YR F N 20050330 MD

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
4626843 1005846416 PS NATALIZUMAB 2 INTRAVENOUS IV D D

Indications of drugs used

Event ID DRUG SEQ INDI PT
4626843 1005846416 MULTIPLE SCLEROSIS

Outcome of event

Event ID OUTC COD
4626843 OT

Reactions reported

Event ID PT
4626843 HYPERSENSITIVITY
4626843 RASH
4626843 SWOLLEN TONGUE

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID RPSR COD
4626843 HP

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
4626843 1005846416 20050207